Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
Impact in
-
- Intensive Care Unit Cognitive Disorders
-
- COVID-19 and healthcare impacts
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 47
- Lung Cancer Diagnosis and Treatment 29
- Gastric Cancer Management and Outcomes 10
- Oncology 58
- Lung Cancer Research Studies 24
- Cancer Immunotherapy and Biomarkers 14
- Top scholars
- D. DebieuvreM GrivauxOlivier MolinierSylvie CourtoisBernard DrénouLaure StielChristophe MathoulinDenis Moro‐Sibilot
- Journals
- Annals of Oncology (13 papers)Journal of Clinical Oncology (9 papers)Annals of Intensive Care (9 papers)Lung Cancer (5 papers)ESMO Open (4 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
188 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 137
- Critical Care and Intensive Care Medicine 108
- Oncology 447
- Infectious Diseases 261
- Pulmonary and Respiratory Medicine 443
- Neurology 186
Countries citing scholars working at Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
This map shows the geographic impact of research produced by authors working at Groupe Hospitalier de la Région de Mulhouse et Sud Alsace. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Groupe Hospitalier de la Région de Mulhouse et Sud Alsace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Groupe Hospitalier de la Région de Mulhouse et Sud Alsace more than expected).
Fields of papers published by authors at Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
This network shows the impact of papers affiliated with Groupe Hospitalier de la Région de Mulhouse et Sud Alsace at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Groupe Hospitalier de la Région de Mulhouse et Sud Alsace at the time of their publication.
About Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
In recent decades, authors affiliated with Groupe Hospitalier de la Région de Mulhouse et Sud Alsace have published 225 papers, which have received a total of 1.6k indexed citations . Scholars at this organization have produced 83 papers in Pulmonary and Respiratory Medicine, 58 papers in Oncology, 9 papers in Critical Care and Intensive Care Medicine, 27 papers in Infectious Diseases and 5 papers in Geriatrics and Gerontology on the topics of Lung Cancer Treatments and Mutations (47 papers), Lung Cancer Diagnosis and Treatment (29 papers), Lung Cancer Research Studies (24 papers), COVID-19 Clinical Research Studies (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Gastric Cancer Management and Outcomes (10 papers), Long-Term Effects of COVID-19 (10 papers) and Health, Medicine and Society (10 papers). Their work is cited by papers focused on Critical Care and Intensive Care Medicine (108 citations), Oncology (447 citations), Infectious Diseases (261 citations), Pulmonary and Respiratory Medicine (443 citations) and Neurology (186 citations). Authors at Groupe Hospitalier de la Région de Mulhouse et Sud Alsace collaborate with scholars in France, United States and United Kingdom and have published in prestigious journals including Annals of Oncology, Journal of Clinical Oncology, Annals of Intensive Care, Lung Cancer and ESMO Open. Some of Groupe Hospitalier de la Région de Mulhouse et Sud Alsace's most productive authors include D. Debieuvre, M Grivaux, Olivier Molinier, Sylvie Courtois, Bernard Drénou, Laure Stiel, Christophe Mathoulin, Denis Moro‐Sibilot, Bernard Asselain and C. Taleb.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.